Clinical study of combinational therapy of AD-4833 with metformin -Phase III double-blind comparative study-

Trial Profile

Clinical study of combinational therapy of AD-4833 with metformin -Phase III double-blind comparative study-

Completed
Phase of Trial: Phase III

Latest Information Update: 12 May 2016

At a glance

  • Drugs Pioglitazone (Primary) ; Metformin
  • Indications Type 2 diabetes mellitus
  • Focus Therapeutic Use
  • Sponsors Takeda
  • Most Recent Events

    • 01 May 2009 Primary endpoint 'Proportion of glycosylated haemoglobin' has been met.
    • 08 May 2008 New trial record.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top